ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #3,235Hybrid

Drug Delivery and Translational Research

Acronym:ddtr
•
Abbreviation (ISO):DRUG DELIV TRANSL RE
•
Identifier (ISSN):2190-393X(Print)/2190-3948(Online)
•
Publisher:Springer US
Clarivate IF (2026)
6.9↑ +1.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Drug Delivery and Translational Research

WoS Q1
14693.420183.1120192.6620204.6220215.6720225.420235.720245.520256.92026
Annual Impact Factor Metric
Current (2026):6.9
Scopus SJR & RankScopus Q1
1.28
#3,235

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
81

81 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate1.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
211articles/year
39.34% Gold OA•80.46% Original Research

Aims & Scope

The journal provides a unique forum for scientific publication of high-quality research that is exclusively focused on translational aspects of drug delivery. Rationally developed, effective delivery systems can potentially affect clinical outcome in different disease conditions. Research focused on the following areas of translational drug delivery research will be considered for publication in the journal. Designing and developing novel drug delivery systems, with a focus on their application to disease conditions; Preclinical and clinical data related to drug delivery systems; Drug distribution, pharmacokinetics, clearance, with drug delivery systems as compared to traditional dosing to demonstrate beneficial outcomes Short-term and long-term biocompatibility of drug delivery systems, host response; Biomaterials with growth factors for stem-cell differentiation in regenerative medicine and tissue engineering; Image-guided drug therapy, Nanomedicine; Devices for drug delivery and drug/device combination products. In addition to original full-length papers, communications, and reviews, the journal includes editorials, reports of future meetings, research highlights, and announcements pertaining to the activities of the Controlled Release Society.

Topics Covered (Recognized by AI)
Biology94.1%Medicine91.3%Chemistry90%Organic chemistry68.4%Materials science68.4%Genetics67.6%Biochemistry63.9%Pharmacology62.4%Engineering59.1%Nanotechnology56.2%Internal medicine54.8%Physics52.3%Chemical engineering45.4%Psychology39.9%Drug delivery39%Psychiatry34.6%Quantum mechanics31.5%Drug28.5%Biotechnology27.5%Pathology27.3%Immunology26%Bioinformatics25.5%Composite material24.2%Chromatography24.2%In vivo23.8%Nanoparticle23%In vitro22%Endocrinology21%Surgery20.5%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q1
Rank35/191
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank34/356
IndexSCIE
JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q1
Rank28/191
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank36/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF6.9
Articles / Year190
Total Citations148
2025
IF5.5
Articles / Year260
Total Citations1,375
2024
IF5.7
Articles / Year267
Total Citations3,746
2023
IF5.4
Articles / Year215
Total Citations3,796
2022
IF5.671
Articles / Year183
Total Citations5,311

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,235Scopus Q1SCImago Profile
Scopus Coverage:2011-2026
Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.28

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
7.83

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,337 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations5,320
3-Year Documents625
Citable Documents613

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate48.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
3区MEDICINE, RESEARCH & EXPERIMENTAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Drug Delivery and Translational Research (acronym: ddtr, abbr: DRUG DELIV TRANSL RE, ISSN: 2190-393X) is a peer-reviewed international scholarly journal in the field of MEDICINE, published by Springer US in Germany since 2011. The periodical holds a Journal Impact Factor (JIF) of 6.90, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.280 (Q1), an H-index of 81.

The journal enforces rigorous peer evaluation with a publication frequency of 12 issues per year, an annual output of approximately 211 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,337 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer US
Publication Language
English
Frequency
12 issues per year
Founding Year
2011
Indexing & Databases
SCIEScopusPubMed
Editorial Address
TIERGARTENSTRASSE 17, HEIDELBERG, GERMANY, D-69121

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: d0daba91-5542-463b-b36c-89ed0c3dfb41
Database Updated: 2026-10-01